129 related articles for article (PubMed ID: 8829181)
1. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist.
Galloway SW; Kingsnorth AN
Pancreas; 1996 Aug; 13(2):140-6. PubMed ID: 8829181
[TBL] [Abstract][Full Text] [Related]
2. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.
Andersson R; Wang X; Sun Z; Deng X; Soltesz V; Ihse I
Pancreas; 1998 Aug; 17(2):107-19. PubMed ID: 9700940
[TBL] [Abstract][Full Text] [Related]
3. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
Leveau P; Wang X; Sun Z; Börjesson A; Andersson E; Andersson R
Biochem Pharmacol; 2005 May; 69(9):1325-31. PubMed ID: 15826603
[TBL] [Abstract][Full Text] [Related]
4. Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
Curtis LD
Adv Exp Med Biol; 1996; 416():361-3. PubMed ID: 9131174
[No Abstract] [Full Text] [Related]
5. Platelet-activating factor.
Kingsnorth AN
Scand J Gastroenterol Suppl; 1996; 219():28-31. PubMed ID: 8865468
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist.
Formela LJ; Wood LM; Whittaker M; Kingsnorth AN
Br J Surg; 1994 Dec; 81(12):1783-5. PubMed ID: 7827939
[TBL] [Abstract][Full Text] [Related]
7. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.
Wang X; Sun Z; Börjesson A; Haraldsen P; Aldman M; Deng X; Leveau P; Andersson R
Int J Pancreatol; 1999 Feb; 25(1):45-52. PubMed ID: 10211421
[TBL] [Abstract][Full Text] [Related]
8. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis.
de Souza LJ; Sampietre SN; Assis RS; Knowles CH; Leite KR; Jancar S; Monteiro Cunha JE; Machado MC
J Gastrointest Surg; 2001; 5(4):364-70. PubMed ID: 11985976
[TBL] [Abstract][Full Text] [Related]
9. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.
Johnson CD; Kingsnorth AN; Imrie CW; McMahon MJ; Neoptolemos JP; McKay C; Toh SK; Skaife P; Leeder PC; Wilson P; Larvin M; Curtis LD
Gut; 2001 Jan; 48(1):62-9. PubMed ID: 11115824
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.
Wang X; Sun Z; Börjesson A; Andersson R
Br J Surg; 1999 Mar; 86(3):411-6. PubMed ID: 10201790
[TBL] [Abstract][Full Text] [Related]
11. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis.
Lane JS; Todd KE; Gloor B; Chandler CF; Kau AW; Ashley SW; Reber HA; McFadden DW
J Surg Res; 2001 Aug; 99(2):365-70. PubMed ID: 11469912
[TBL] [Abstract][Full Text] [Related]
12. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats.
Liu Q; Djuricin G; Rossi H; Bewsey K; Nathan C; Gattuso P; Weinstein RA; Prinz RA
Am Surg; 1999 Jul; 65(7):611-6; discussion 617. PubMed ID: 10399968
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
Keck T; Balcom JH; Fernández-del Castillo C; Antoniu BA; Warshaw AL
Gastroenterology; 2002 Jan; 122(1):188-201. PubMed ID: 11781293
[TBL] [Abstract][Full Text] [Related]
14. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials.
Abu-Zidan FM; Windsor JA
Eur J Surg; 2002; 168(4):215-9. PubMed ID: 12440758
[TBL] [Abstract][Full Text] [Related]
15. The use of lexipafant in the treatment of acute pancreatitis.
McKay C; Curran FJ; Sharples CE; Young CA; Baxter JN; Imrie CW
Adv Exp Med Biol; 1996; 416():365-70. PubMed ID: 9131175
[TBL] [Abstract][Full Text] [Related]
16. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
Börjesson A; Wang X; Sun Z; Inghammar M; Truedsson L; Andersson R
Dig Liver Dis; 2002 Mar; 34(3):190-6. PubMed ID: 11990391
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis.
Muhs BE; Patel S; Yee H; Marcus S; Shamamian P
J Surg Res; 2003 Feb; 109(2):110-7. PubMed ID: 12643851
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of reduction of pancreatic enzyme content on the pulmonary disease induced by acute pancreatitis].
Alves Júnior A; Coelho AM; Sampietre SN; Kubrusly MS; Molan NT; Machado MC; Pinotti HW
Arq Gastroenterol; 1996; 33(3):136-44. PubMed ID: 9201326
[TBL] [Abstract][Full Text] [Related]
19. Modulation of lung injury by platelet-activating factor antagonism in nonhypotensive porcine endotoxemia.
Abu-Zidan FM; Walther S; Lennquist S
Circ Shock; 1994 Nov; 44(3):148-53. PubMed ID: 7600638
[TBL] [Abstract][Full Text] [Related]
20. [Physiopathology of lung injury in acute pancreatitis].
Alves Júnior A; Coelho AM; Sampietre SN; Kubrusly MS; Molan NA; Leite KR; Jancar S; Machado MC; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):232-8. PubMed ID: 9239897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
